Related Experiment Videos
Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570)
A Liepins1, J W Nowicky, J O Bustamante
1Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada.
Abstract:
Selective induction of malignant cell death is one of the major goals of effective and safe chemotherapy. Recent developments in the understanding of programmed cell death (PCD) or apoptosis are expected to provide new leads for a safer chemotherapy. The authors investigated whether the semisynthetic alkaloid thiophosphoric acid derivative Ukrain (NSC-631570) could induce PCD or apoptosis in human K562 leukaemia cells. Results showed that Ukrain induced two distinct modalities of cell death programmes. One modality corresponded morphologically to classical apoptosis or PCD characterized by blebbing and shedding of membrane vesicles with concomitant 51Cr release; however, the Ukrain-induced apoptosis was not associated with the characteristic nuclear DNA fragmentation. Higher concentrations of Ukrain induced a second cell death programme characterized by cell surface blister formation, high specific 51Cr release and extensive DNA polyploidy. These two cell death programmes are distinct from each other in that they are interphased by a silent period characterized by normal cell morphology and reduced specific 51Cr release.
Insights
The chemotherapy drug Ukrain induces programmed cell death (PCD) in leukemia cells through two distinct mechanisms. One resembles apoptosis, while the other involves cell surface blistering and DNA polyploidy.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Selective induction of cancer cell death is crucial for effective chemotherapy.
- Understanding programmed cell death (PCD), or apoptosis, offers potential for safer cancer treatments.
Purpose of the Study:
- To investigate if Ukrain, a thiophosphoric acid derivative, can induce PCD in human K562 leukemia cells.
- To characterize the specific mechanisms of cell death induced by Ukrain.
Main Methods:
- Human K562 leukemia cells were treated with Ukrain (NSC-631570).
- Cell death modalities were assessed using morphological analysis and 51Cr release assays.
- DNA fragmentation and polyploidy were evaluated.
Main Results:
- Ukrain induced two distinct cell death pathways in K562 cells.
- The first pathway mimicked classical apoptosis with membrane blebbing and 51Cr release, but lacked DNA fragmentation.
- The second pathway, at higher concentrations, featured cell surface blistering, high 51Cr release, and DNA polyploidy.
Conclusions:
- Ukrain triggers unique cell death programs in leukemia cells, distinct from classical apoptosis.
- These findings suggest Ukrain's potential as a novel chemotherapeutic agent with a unique mechanism of action.